May 29, 2026

New HI-STEM Publication: A kinetics-based model of haematopoiesisreveals extrinsic regulation of skewed lineageoutput from stem cells

New HI-STEM Publication: A kinetics-based model of haematopoiesisreveals extrinsic regulation of skewed lineageoutput from stem cells

Rodríguez-Correa, E., Grünschläger, F., Nizharadze, T. et al. A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells. Nat Cell Biol (2026). https://doi.org/10.1038/s41556-026-01958-0

https://www.nature.com/articles/s41556-026-01958-0

Abstract

Haematopoietic stem cells (HSCs) display extensive molecular and functional heterogeneity. However, a cohesive model that explains the relationship and biological relevance of these diverse HSC states remains elusive. Here, by performing single-cell transplantations of over 1,000 highly purified murine long-term HSCs combined with in-depth phenotyping of their clonal progeny, we define kinetics-based reconstitution parameters which aligned HSCs into a single hierarchical trajectory reflective of functional potency. This approach revealed that previously identified lineage biases are actually transitory states along this linear trajectory, not a discrete stable condition. Single-cell secondary transplantations validated hierarchical ordering based on reconstitution kinetics, whereas mathematical modelling combined with experimental modulation of lineage-biased blood production revealed that apparent lineage-biased outputs actually arise from cell-extrinsic feedback regulation and clonal competition between slow- and fast-engrafting clones to fill mature lineages to their compartment size limit. This study reconciles multiple layers of HSC heterogeneity into a unifying framework.

Our latest News

discover more
How is TR-FRET Used in Drug Discovery?

How is TR-FRET Used in Drug Discovery?

This post is Part 2 of a two-part blog series. Read part 1: What is a TR‑FRET assay and how is it used in drug discovery? In a previous blog post, we covered the fundamental principles of Time-Resolved Fluorescence (TR) Förster Resonance Energy Transfer (TR-FRET), including how long-lived lanthanide donors like europium enable high-sensitivity, “mix-and-read” assays. Because TR-FRET provides a ratiometric, proximity-based […]

Triple ERC Success at the German Cancer Research Center

Triple ERC Success at the German Cancer Research Center

Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine. With the funding, they plan to investigate why certain brain […]

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM) have identified a previously unknown mechanism that can drive cancer cachexia – a wasting process in the body that primarily affects muscle and fat tissue. A central role is […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp